Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method
- PMID: 18355366
- DOI: 10.1111/j.1471-0528.2008.01690.x
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method
Abstract
Objective: To evaluate impact of different postmenopausal hormone therapy (HT) regimens and raloxifene on mammographic breast density.
Design: Open, randomised, comparative clinical trial.
Setting: Women were recruited through local newspapers and posters. They were examined at the Departments of Haematology, Gynaecology, and Radiology in a University Hospital.
Population: A total of 202 healthy postmenopausal women between the age of 45 and 65 years.
Methods: Women were randomly assigned to receive daily treatment for 12 weeks with tablets containing low-dose HT containing 1 mg 17 beta-estradiol + 0.5 mg norethisterone acetate (NETA) (n = 50), conventional-dose HT containing 2 mg 17 beta-estradiol and 1 mg NETA (n = 50), 2.5 mg tibolone (n = 51), or 60 mg raloxifene (n = 51). Mammographic density was determined at baseline and after 12 weeks by an automated technique in full-field digital mammograms.
Main outcome measures: Mammographic density was expressed as volumetric breast density estimations.
Results: Mammographic breast density increased significantly and to a similar degree in both the conventional- and low-dose HT groups. A small reduction in mammographic breast density was seen in the raloxifene group, whereas those allocated to tibolone treatment only showed minor changes.
Conclusions: Our findings demonstrated a significant difference in impact on mammographic breast density between the regimens. Although these results indicate a differential effect of these regimens on breast tissue, the relation to breast cancer risk remains unresolved.
Similar articles
-
Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.Climacteric. 2009 Jun;12(3):248-58. doi: 10.1080/13697130802638458. Climacteric. 2009. PMID: 19387884
-
Effects of tibolone on the breast of postmenopausal women.Taiwan J Obstet Gynecol. 2007 Jun;46(2):121-6. doi: 10.1016/S1028-4559(07)60005-9. Taiwan J Obstet Gynecol. 2007. PMID: 17638619 Review.
-
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.Thromb Haemost. 2007 Jun;97(6):938-43. Thromb Haemost. 2007. PMID: 17549295 Clinical Trial.
-
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.Thromb Res. 2007;120(3):371-9. doi: 10.1016/j.thromres.2006.10.013. Epub 2006 Dec 15. Thromb Res. 2007. PMID: 17156824 Clinical Trial.
-
The effects of tibolone and oestrogen-based HT on breast cell proliferation and mammographic density.Maturitas. 2004 Sep 24;49(1):S16-21. doi: 10.1016/j.maturitas.2004.06.011. Maturitas. 2004. PMID: 15351103 Review.
Cited by
-
The Relationship Between Breast Density and Breast Cancer Surgical Outcomes: A Systematic Review.Cureus. 2024 Mar 30;16(3):e57265. doi: 10.7759/cureus.57265. eCollection 2024 Mar. Cureus. 2024. PMID: 38686256 Free PMC article. Review.
-
Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.Oncotarget. 2017 Jan 17;8(3):5578-5591. doi: 10.18632/oncotarget.13484. Oncotarget. 2017. PMID: 27894075 Free PMC article. Review.
-
Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet: A Systematic Review.Integr Cancer Ther. 2016 Jun;15(2):127-44. doi: 10.1177/1534735416628343. Epub 2016 Apr 29. Integr Cancer Ther. 2016. PMID: 27130722 Free PMC article.
-
Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.Breast Cancer Res. 2014 Jun 18;16(3):212. doi: 10.1186/bcr3677. Breast Cancer Res. 2014. PMID: 25928299 Free PMC article. Review.
-
Effect of preventive hormonal therapy on breast density: a systematic qualitative review.ScientificWorldJournal. 2014;2014:942386. doi: 10.1155/2014/942386. Epub 2014 Apr 27. ScientificWorldJournal. 2014. PMID: 24895676 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical